Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2018

Dec 22, 2018

62616_rns_2018-12-22_a7e173dd-0c7d-4349-9b54-c3cd732a66f5.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

December 21, 2018

BSE Limited

BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E) Mumbai - 400 051 Scrip code: 532531 Scrip code: STAR

Dear Sirs,

Sub: Intimation under Reg 30 of SEBI Listing Regulations

Ref: Update on completion of investment in Strides Consumer Healthcare Business

We refer to our earlier correspondence of October 31, 2018 relating to Strides’ partnering with ICP-III Investment Advisors for funding in its nascent Consumer Healthcare Business.

India Life Sciences Fund III advised by ICP-III Investment Advisors has partnered with Strides and the said transaction has achieved closure on December 20, 2018.

This is for your information and records.

For Strides Pharma Science Limited

Sd/Manjula Ramamurthy Company Secretary

Strides Pharma Science Limited

(Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 [email protected]; www.strides.com